[Spironolactone reduces blood pressure and albuminuria of obese hypertensive patients with metabolic syndrome]. [electronic resource]
Producer: 20140414Description: 69-72 p. digitalISSN:- 2175-8239
- Adolescent
- Adult
- Albuminuria -- complications
- Blood Pressure -- drug effects
- Female
- Humans
- Hypertension -- complications
- Male
- Metabolic Syndrome -- complications
- Middle Aged
- Mineralocorticoid Receptor Antagonists -- pharmacology
- Obesity -- complications
- Prospective Studies
- Spironolactone -- pharmacology
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.